title: [New drug forms of molsidomine, Corvaton-forte and Corvaton-retard, and their antianginal efficacy in stenocardia patients].
authors.forename: S K
authors.initials: SK
authors.lastname: Kukushkin
authors.forename: V M
authors.initials: VM
authors.lastname: Shamarin
authors.forename: E M
authors.initials: EM
authors.lastname: Manoshkina
authors.forename: N V
authors.initials: NV
authors.lastname: Berzak
authors.forename: K Iu
authors.initials: KIu
authors.lastname: Petrosian
mesh_terms: D000787:Angina Pectoris / Q000175:diagnosis / Q000188:drug therapy*; D002908:Chronic Disease; D003692:Delayed-Action Preparations; D004341:Drug Evaluation; D005080:Exercise Test; D005260:Female; D006801:Humans; D008297:Male; D008875:Middle Aged; D008981:Molsidomine / Q000008:administration & dosage* / Q000009:adverse effects; D013607:Tablets; D014665:Vasodilator Agents / Q000008:administration & dosage* / Q000009:adverse effects
chemical_list: D003692:Delayed-Action Preparations; D013607:Tablets; D014665:Vasodilator Agents; D008981:Molsidomine
vernacular_title: Novye lekarstvennye formy molsidomina korvaton-forte i korvaton-retarda i ikh antianginal'naia éffektivnost' u bol'nykh stenokardieĭ.